Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
Authors
Keywords
DCE-MRI, Hepatocellular carcinoma, Anti-angiogenic treatment, Quantitative perfusion MRI, Image biomarker
Journal
EUROPEAN RADIOLOGY
Volume 27, Issue 7, Pages 3069-3079
Publisher
Springer Nature
Online
2016-12-12
DOI
10.1007/s00330-016-4670-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy
- (2016) Bang-Bin Chen et al. RADIOLOGY
- Dynamic Contrast-Enhanced MRI Kinetic Parameters as Prognostic Biomarkers for Prediction of Survival of Patient with Advanced Hepatocellular Carcinoma
- (2015) Sang Ho Lee et al. ACADEMIC RADIOLOGY
- Early effects of low dose bevacizumab treatment assessed by magnetic resonance imaging
- (2015) Jon-Vidar Gaustad et al. BMC CANCER
- Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver
- (2015) Julius Chapiro et al. EUROPEAN RADIOLOGY
- Interreader and inter-test agreement in assessing treatment response following transarterial embolization for hepatocellular carcinoma
- (2015) Olivio F. Donati et al. EUROPEAN RADIOLOGY
- Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis
- (2015) Michael A. Fischer et al. EUROPEAN RADIOLOGY
- DCE-MRI of hepatocellular carcinoma: perfusion quantification with Tofts model versus shutter-speed model—initial experience
- (2015) Guido H. Jajamovich et al. MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE
- Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?
- (2015) Yu-Yun Shao WORLD JOURNAL OF GASTROENTEROLOGY
- A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib
- (2015) AG Duffy et al. United European Gastroenterology Journal
- Volumetric assessment of tumour response using functional MR imaging in patients with hepatocellular carcinoma treated with a combination of doxorubicin-eluting beads and sorafenib
- (2014) Celia Pamela Corona-Villalobos et al. EUROPEAN RADIOLOGY
- Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators
- (2014) Martin D. Pickles et al. EUROPEAN RADIOLOGY
- New approaches for precise response evaluation in hepatocellular carcinoma
- (2014) Koichi Hayano WORLD JOURNAL OF GASTROENTEROLOGY
- DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker
- (2014) Bang-Bin Chen WORLD JOURNAL OF GASTROENTEROLOGY
- Novel functional magnetic resonance imaging biomarkers for assessing response to therapy in hepatocellular carcinoma
- (2013) Z. Yuan et al. Clinical & Translational Oncology
- Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy
- (2013) Dushyant V Sahani et al. Journal of Hematology & Oncology
- Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts
- (2013) Siver A. Moestue et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Diffusion and perfusion MRI prediction of progression-free survival in patients with hepatocellular carcinoma treated with concurrent chemoradiotherapy
- (2013) Kyung Ah Kim et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
- (2012) Chiun Hsu et al. JOURNAL OF HEPATOLOGY
- Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma
- (2012) Tao Jiang et al. JOURNAL OF HEPATOLOGY
- Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies
- (2012) James P. B. O'Connor et al. Nature Reviews Clinical Oncology
- Antiangiogenic Therapy for Primary Liver Cancer: Correlation of Changes in Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Tissue Hypoxia Markers and Clinical Response
- (2011) Adam C. Yopp et al. ANNALS OF SURGICAL ONCOLOGY
- Monitoring Response to Antiangiogenic Treatment and Predicting Outcomes in Advanced Hepatocellular Carcinoma Using Image Biomarkers, CT Perfusion, Tumor Density, and Tumor Size (RECIST)
- (2011) Tao Jiang et al. INVESTIGATIVE RADIOLOGY
- Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
- (2011) Chao-Yu Hsu et al. JOURNAL OF HEPATOLOGY
- DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model
- (2011) Benjamin A. Hoff et al. NMR IN BIOMEDICINE
- Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival
- (2009) W. R. Jarnagin et al. ANNALS OF ONCOLOGY
- Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
- (2009) Andrew X. Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
- (2009) Sean F. Altekruse et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now